PLAY PODCASTS
63. Advanced Grade 3 Neuroendocrine Tumours - Chemotherapy options

63. Advanced Grade 3 Neuroendocrine Tumours - Chemotherapy options

Part 3

Oncology for the Inquisitive Mind · Michael Fernando and Josh Hurwitz

September 16, 202329m 56s

Audio is streamed directly from the publisher (sphinx.acast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Neuroendocrine Tumours could be described as an impassable obstacle, more complicated the more you research. That's where Michael and Josh come in, and this week, explore Grade 3 metastatic neuroendocrine tumours. Michael provides a brilliant overview of this well-differentiated cohort and the lack of efficacy platinum chemotherapies have, while Josh discusses CAPTEM (temozolomide and capecitabine) through a systematic review. Interestingly many of the current data is retrospectively collected, highlighting how challenging it is to collect enough patients to pursue meaningful research.


Note- there is a quote from Lance Armstrong, who was stripped of his titles due to illegal doping (which we do not endorse); he did start the Livestrong Foundation to support those affected by cancer.


Links to studies discussed in this episode (subscription may be required):

1. Review - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158108/

2. Cape/tem - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790144/

3. Platinum-based chemo: https://erc.bioscientifica.com/view/journals/erc/20/5/649.xml


For more episodes, resources and blog posts, visit www.inquisitiveonc.com

Please find us on Twitter @InquisitiveOnc!

If you want us to look at a specific trial or subject, email us at [email protected]


Art courtesy of Taryn Silver

Music courtesy of Music Unlimited: https://pixabay.com/users/music_unlimited-27600023/


Disclaimer: This podcast is for educational purposes only. If you are unwell, seek medical advice.


Hosted on Acast. See acast.com/privacy for more information.